Complications of Long-Term Pantoprazole Use
Introduction to Complications
- Long-term pantoprazole use is associated with several potential complications, including bone fractures, vitamin B-12 deficiency, magnesium deficiency, kidney problems, and increased risk of infections, requiring regular evaluation of continued need and appropriate monitoring, as recommended by the American Gastroenterological Association 1
Major Complications
Bone Health Complications
- PPIs can lower stomach acid levels, decreasing calcium absorption and increasing fracture risk, according to the American Geriatrics Society 2
Gastrointestinal Complications
- Increased risk of Clostridium difficile infection, as reported by the European Society of Cardiology 3
Rebound Acid Hypersecretion
- Rebound acid hypersecretion is common after discontinuation of long-term PPI therapy, as noted by the American Gastroenterological Association, although this fact is also reported by Praxis Medical Insights, the American Gastroenterological Association is chosen for this fact 1
Monitoring Recommendations
Regular Indication Review
- All patients taking a PPI should have regular review of ongoing indications for use and documentation of that indication, as recommended by the American Gastroenterological Association 1
- The primary care provider should be responsible for reviewing the presence of ongoing indications for PPI use, according to the American Gastroenterological Association, although Praxis Medical Insights also reports this, the American Gastroenterological Association is chosen for this fact 1
De-prescribing Considerations
When to Consider De-prescribing
- All patients without a definitive indication for chronic PPI should be considered for trial of de-prescribing, as recommended by the American Gastroenterological Association 1
- Most patients with twice-daily dosing should be considered for step-down to once-daily PPI, according to the American Gastroenterological Association 1
When Not to De-prescribe
- Patients with complicated GERD, such as those with a history of severe erosive esophagitis, esophageal ulcer, or peptic stricture, should generally not be considered for PPI discontinuation, as recommended by the American Gastroenterological Association 1
- Patients with Barrett's esophagus, severe erosive esophagitis, or high risk for GI bleeding should continue PPI therapy, although both the American Gastroenterological Association and Praxis Medical Insights report this, the American Gastroenterological Association is chosen for this fact 1
Appropriate Long-Term Indications
Definite Indications for Long-Term Use
- Barrett's esophagus, as recommended by the American Gastroenterological Association 1
- Severe erosive esophagitis (LA Classification grade C/D), according to the American Gastroenterological Association 1
- Gastroprotection in high-risk NSAID/aspirin users, as recommended by the American Gastroenterological Association 1
- Secondary prevention of gastric/duodenal ulcers, according to the American Gastroenterological Association 1
- Zollinger-Ellison Syndrome, as recommended by the American Gastroenterological Association 1
Conditional Indications for Long-Term Use
- PPI-responsive endoscopy-negative reflux disease with symptom recurrence after discontinuation, as recommended by the American Gastroenterological Association 1
- Esophageal strictures from GERD, according to the American Gastroenterological Association 1